CDT EQUITY INC. Current Assets
CDT EQUITY INC. (CDT) had Current Assets of $2.94 million as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-08
- 2026-06-30: Assets, Current $2.94M.
- 2026-03-31: Assets, Current $3.05M.
- 2025-12-31: Assets, Current $4.38M.
- 2025-09-30: Assets, Current $7.09M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.94M S-1 · filed 2026-09-08 | |
| 2026-03-31 | $3.05M 10-Q · filed 2026-07-15 | |
| 2025-12-31 | $4.38M S-1 · filed 2026-09-08 | |
| 2025-09-30 | $7.09M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.39M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $5.95M 10-Q/A · filed 2025-08-14 | |
| 2024-12-31 | $2.71M S-1 · filed 2026-09-08 | |
| 2024-09-30 | $1.40M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.60M 10-Q/A · filed 2024-11-14 | |
| 2024-03-31 | $3.16M 10-Q/A · filed 2024-11-14 | |
| 2023-12-31 | $5.73M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $10.44M 10-Q/A · filed 2023-11-21 | |
| 2023-06-30 | $895.00K 10-Q · filed 2024-08-12 | $354.49K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $501.00K 10-Q/A · filed 2024-11-14 | $310.02K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $646.64K 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $1.15M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $1.33M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.45M 10-Q · filed 2022-05-18 | |
| 2021-12-31 | $104.16K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |